Request Demo
Last update 08 May 2025
Chloramphenicol/Fradiomycin Sulfate/Prednisolone
Last update 08 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Chloramphenicol/Neomycin/Prednisolone, CHLOMYⓇ-P, HYSETIN-P + [2] |
Target |
Action inhibitors |
Mechanism 30S subunit inhibitors(30S ribosomal subunit inhibitors), Protein biosynthesis inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (09 Nov 1959), |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC23H46N6O13 |
InChIKeyPGBHMTALBVVCIT-VCIWKGPPSA-N |
CAS Registry119-04-0 |
View All Structures (3)
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Skin and skin structure infections | Japan | 15 Mar 1994 | |
| Dermatitis | Japan | 09 Nov 1959 | |
| Eczema | Japan | 09 Nov 1959 | |
| Pyoderma | Japan | 09 Nov 1959 | |
| Secondary infection | Japan | 09 Nov 1959 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | HER2 Positive Breast Cancer Neoadjuvant | 215 | mvalehewld(eftphkviwy) = jgjwiqjcas libhcrzdgt (fmbssiscqf ) View more | Positive | 25 May 2020 | ||
Not Applicable | HER2 Positive Breast Cancer Neoadjuvant | 219 | NAC+T | (rqzzwqxydm) = cnreswbagb jjbgdebcyh (fjdibsioip ) View more | Positive | 01 Jun 2018 | |
(rqzzwqxydm) = nxhwkalxce jjbgdebcyh (fjdibsioip ) View more | |||||||
Phase 2 | 81 | (klaeubsfwm) = ulvjxicguo rmuskpgutk (wobajwoknc ) View more | Negative | 01 Jul 2017 | |||
(klaeubsfwm) = ioxtrdfcxc rmuskpgutk (wobajwoknc ) View more | |||||||
Phase 3 | 368 | X+P | (rxxsdipmaf) = PFS and OS are similar at a median follow-up of 15.5 months slbvfbgbsq (rsaetfchjo ) View more | - | 20 Jun 2006 | ||
X+T | |||||||
Not Applicable | 718 | (zycfgnfpzv) = 48.3% patients on D & 49.1% patients on E had grade III & IV neutropenia ktbutbownp (atrbpauctu ) View more | - | 15 Jul 2004 | |||
Phase 2 | Non-Small Cell Lung Cancer Consolidation | - | NVB oral + P | qktfqhblho(cmfdvixbvk) = kkewvcqvua lrvcyjlqpn (ixwwpanbdd ) View more | Positive | 15 Jul 2004 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free